$228 Million is the total value of Argyle Capital Management Inc.'s 112 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 36.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
T | Buy | AT&T Inc. | $4,207,000 | -4.3% | 125,242 | +0.4% | 1.85% | -8.9% |
IBM | Buy | International Business Mach | $3,922,000 | -14.4% | 24,446 | +1.2% | 1.72% | -18.5% |
COP | Buy | ConocoPhillips | $3,608,000 | -1.3% | 52,244 | +9.4% | 1.58% | -5.9% |
CVX | Buy | Chevron Corporation | $3,311,000 | +2.6% | 29,511 | +9.1% | 1.45% | -2.2% |
BAX | Buy | Baxter Intl Inc | $2,967,000 | +13.1% | 40,479 | +10.7% | 1.30% | +7.8% |
MET | Buy | MetLife Inc | $2,366,000 | +3.8% | 43,750 | +3.1% | 1.04% | -1.1% |
GM | Buy | General Mtrs Corp | $2,194,000 | +9.5% | 62,850 | +0.2% | 0.96% | +4.3% |
HAL | Buy | Halliburton Co | $2,051,000 | -26.8% | 52,150 | +20.2% | 0.90% | -30.2% |
BP | Buy | BP PLCsponsored adr | $1,981,000 | -9.5% | 51,974 | +4.4% | 0.87% | -13.8% |
FCX | New | Freeport-McMoRan Inccl b | $1,103,000 | – | 47,200 | +100.0% | 0.48% | – |
WFC | Buy | Wells Fargo & Co New | $1,051,000 | +99.8% | 19,167 | +89.0% | 0.46% | +90.5% |
KMT | New | Kennametal Inc | $934,000 | – | 26,100 | +100.0% | 0.41% | – |
F | New | Ford Motor Co Del | $646,000 | – | 41,674 | +100.0% | 0.28% | – |
BAC | Buy | Bank of America Corp | $612,000 | +18.8% | 34,234 | +13.2% | 0.27% | +13.1% |
KMI | New | Kinder Morgan Inc Del | $490,000 | – | 11,575 | +100.0% | 0.22% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-01-26
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Microsoft Corp | 42 | Q3 2023 | 5.3% |
Merck & Co Inc | 42 | Q3 2023 | 3.2% |
Pfizer Inc | 42 | Q3 2023 | 2.8% |
Amgen Inc | 42 | Q3 2023 | 2.9% |
Intel Corp | 42 | Q3 2023 | 3.1% |
Bristol Myers Squibb Co | 42 | Q3 2023 | 2.9% |
Paychex Inc | 42 | Q3 2023 | 2.3% |
Lilly Eli Co | 42 | Q3 2023 | 4.4% |
Verizon Communications | 42 | Q3 2023 | 2.6% |
Johnson & Johnson | 42 | Q3 2023 | 2.2% |
View Argyle Capital Management Inc.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-29 |
13F-HR | 2024-02-05 |
13F-HR | 2023-10-26 |
13F-HR | 2023-07-27 |
13F-HR | 2023-04-27 |
13F-HR | 2023-02-06 |
13F-HR | 2022-10-21 |
13F-HR | 2022-07-20 |
13F-HR | 2022-04-27 |
13F-HR | 2022-01-25 |
View Argyle Capital Management Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.